Navigation Links
Reportlinker Adds Bevacizumab - Comprehensive Patent Search
Date:2/1/2011

NEW YORK, Feb. 1, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Bevacizumab - Comprehensive patent search

http://www.reportlinker.com/p0366187/Bevacizumab---Comprehensive-patent-search.html

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information.

Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.

This Pipeline Developer report covers Bevacizumab

Bevacizumab indications: In combination with 5-Fluorouracil based chemotherapy for metastatic carcinoma of the colon or rectum; in combination with Carboplatin and Paclitaxel for non-squamous, non-small cell lung cancer; in combination with Paclitaxel for metastatic breast cancer

Bevacizumab innovator: Roche (Avastin)

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.

Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.

Pipeline Developer features: # Comprehensive patent searching, covering the world's key territories (see 'search coverage' below)

# Identifies patents covering molecule, formulation, process, use, combination and assay techniques (see 'Patent Categories Identified' below)

# Patent identification, categorisation and interpretation

# Grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims

# Manual filtration of patents not relevant to generic development

# Updated on a monthly basis, including changes to patent families, statuses, and litigation

# Enables fast analysis and verification by hyper-linking to crucial patent documents and national registers

Patent Categories Identified: 1. Molecular Form

a) Molecule Patents

b) Salts, Hydrates & Solvates

c) Polymorphic Forms

d) Other Molecular Forms

2. Active Ingredient Preparation

a) Intermediates & Preparation Thereof

b) Final Synthetic Stages

c) Complete Synthesis

d) Purification Methods

e) Fermentation Methods

f) Biotechnology

3. Formulations & Methods Thereof

a) General Formulations & Methods

b) Injectable Formulations

c) Oral Formulations

d) Other Administration-Specific Formulations

e) Excipients, Kits & Packaging

4. Related Medical Use & Administration

a) New Use Related to Main Indication

b) Dosing Regimen/Administration Conditions

5. Active Ingredient Combinations

a) Novel Combinations

b) Use of Combinations

c) Dosing Regimen & Administration Conditions for Combinations

6. Analytical Methods

a) Assaying Methods

b) Methods of Determining Patient Suitability

Search coverage: Clicking on a patent family displays detailed information on the 'Core' and 'Non-Core' 'Patent Family Equivalents'. 'Core Patent Family Equivalents' are equivalent patents from territories that are individually verified and monitored for changes, including British, German, Spanish, French, US, Canadian, Australian, European, and PCT patents. Statuses are also monitored and updated. 'Extended Patent Family Equivalents' are equivalent patents found through the INPADOC database, increasing the search coverage to 70 countries.

Patent and national register access:Clicking on a listed patent/application number or text or image link will launch a pop-up window containing an image of the patent, enabling easy analysis of the patent documents. Clicking on a register link launches a pop-up window with the patent office register extract for that patent. This allows investigation into the examination status of a pending patent, opposition of a granted patent and/or payment of maintenance fees. Please note that no extra charges apply to accessing or downloading documents of any kind.

Litigation alerts:Informing you of developments in court, litigation alerts can also be accessed by clicking on the litigation symbol next to the status, with links to judgments where available.

Updating:To take the time and hassle out of monitoring and updating a large number of patents, all Pipeline Developer reporting is updated on a monthly basis. Convenient change flags identify new patent families, new patent family members, changes in statuses and litigation alerts.

Legal status and transaction history:You can also find legal status and transaction history for 'Extended Patent Family Equivalents' by clicking on the INPADOC Family/Legal Status button for 65 additional territories.

Reporting and access:All data can be exported into Microsoft Excel and print friendly versions for ease of data manipulation and reporting. Company details are confidential and all data is SSL secure. Five users per company are permitted and access levels are controlled by a nominated 'company administrator'.

Pipeline Developer is just one of the benchmark products from GenericsWeb's Pipeline Patent Intelligence product suite.

To order this report:: Bevacizumab - Comprehensive patent search

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!CONTACT:  Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects
2. Reportlinker Adds The 2011 US Coagulation Market
3. Reportlinker Adds In-vitro and Companion Diagnostics Industry - 2010 Yearbook
4. Reportlinker Adds X-Ray Systems Market to 2016 - The Digital X-Ray Systems Segment to be the Growth Driver
5. Reportlinker Adds The 2011 Top Ten Worlds Leading Pharmaceutical Companies
6. Reportlinker Adds The 2011 Top Ten Worlds Leading Diagnostic Imaging Companies
7. Reportlinker Adds The Drug Discovery Outsourcing Market
8. Reportlinker Adds The Top 10 CMOs in China
9. Reportlinker Adds Brand Erosion Post-Patent Expiry - An analysis of small molecule brand erosion post-patent expiry
10. Reportlinker Adds The 2011 Blood Banking Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers
11. Reportlinker Adds Emerging Regional Markets for Therapeutic Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2017)... PORTLAND, Ore. , May 9, 2017 /PRNewswire/ ... company that provides technology solutions to improve the ... reported financial results for the first quarter ended ... that our products enable our customers to identify ... them to intervene before events like heart attacks ...
(Date:5/8/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO)., has completed its acquisition ... care service center company based in Chantilly, ... management programs for leading pharmaceutical manufacturers and health care ... will join Envoy Health Management, LLC , as ... firms, and other service companies. Together, WRB and EnvoyHealth ...
(Date:5/6/2017)... is Stroke Awareness Month and Omron Healthcare is reminding ... prevent a stroke: monitor and manage your blood pressure. ... undetected and uncontrolled hypertension is a leading risk factor ... personal heart health technology, recently evolved its mission to ... and is advancing a national public education effort to ...
Breaking Medicine Technology:
(Date:5/28/2017)... ... May 28, 2017 , ... ... proud to announce that Sheldon K. Cho, MD, has joined its Winter Haven ... specialty that concentrates on minimally invasive techniques to treat and manage many types ...
(Date:5/27/2017)... ... May 26, 2017 , ... A May 8 article ... doctor for colds or respiratory issues that are not responsive to antibiotics nevertheless obtain ... doctors may be largely responsible for the problem both in Canada and the United ...
(Date:5/27/2017)... ... May 27, 2017 , ... In any business, follow up is ... of your dental team at presenting treatment, there will always be some patients who ... time and money on best practices when it comes to presenting treatment. After ...
(Date:5/27/2017)... ... , ... Most us are familiar with the sound of occasional popping joints ... Initiative shows that certain people who experience consistent joint popping, grating and grinding ... the opportunity to treat patients before the problem becomes pronounced, potentially hedging off more ...
(Date:5/26/2017)... ... May 26, 2017 , ... The American Parkinson ... more than eighty-nine grant submissions all vying for nearly $1,000,000 in funding that ... field.     , The American Parkinson Disease Association (APDA) is focused on advancing scientific ...
Breaking Medicine News(10 mins):